Performance of the Fecal Immunochemical Test for Colorectal Cancer Screening Using Different Stool-Collection Devices: Preliminary Results from a Randomized Controlled Trial

Hye-Young SHIN; Mina SUH; Hyung-Won BAIK; Kui-Son CHOI; Boyoung PARK; Jae-Kwan JUN; Sang-Hyun HWANG; Byung-Chang KIM; Chan-Wha LEE; Jae-Hwan OH; You-Kyoung LEE; Dong-Soo HAN; Do-Hoon LEE.
Gut and Liver ; : 925-931, 2016.
Artículo en Inglés | WPRIM | ID: wpr-132232

Documentos relacionados

  1. Screening uptake of colonoscopy versus fecal immunochemical testing in first-degree relatives of patients with non-syndromic colorectal cancer: A multicenter, open-label, parallel-group, randomized trial (ParCoFit study).
  2. Effective strategies for Fecal Immunochemical Tests (FIT) programs to improve colorectal cancer screening uptake among populations with limited access to the healthcare system: a rapid review.
  3. Performance of the Fecal Immunochemical Test for Colorectal Cancer Screening Using Different Stool-Collection Devices: Preliminary Results from a Randomized Controlled Trial.
  4. Cancer screening with multicancer detection tests: A translational science review.
  5. [Value of fecal immunochemical test in colorectal cancer screening].
  6. Instrumental variables methods reconcile intention-to-screen effects across pragmatic cancer screening trials.
  7. Colonoscopy decreases mortality in colorectal cancer patients compared with fecal immunochemical test.
  8. Comparison of Colonoscopy, Fecal Immunochemical Test, and Risk-Adapted Approach in a Colorectal Cancer Screening Trial (TARGET-C).
  9. Risk of colonoscopy-related complications in a fecal immunochemical test-based population colorectal cancer screening program.
  10. Colorectal cancer screening completion by patients due or overdue for screening after reminders: a retrospective study.